Research ArticleClinical Studies

Clinical Trial of Photodynamic Therapy Using Acridine Orange with/without Low Dose Radiation as New Limb Salvage Modality in Musculoskeletal Sarcomas

KATSUYUKI KUSUZAKI, HIROAKI MURATA, TAKAO MATSUBARA, SHINICHI MIYAZAKI, ATSUSHI OKAMURA, MASASHI SETO, AKIHIKO MATSUMINE, HAJIME HOSOI, TOURU SUGIMOTO and ATSUMASA UCHIDA
Anticancer Research March 2005, 25 (2B) 1225-1235;

Article Information

vol. 25 no. 2B 1225-1235
PubMed 
15865070
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received September 20, 2004
  • Accepted December 20, 2004
  • Published online March 1, 2005.
Copyright & Usage 
Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. KATSUYUKI KUSUZAKI1,
  2. HIROAKI MURATA2,
  3. TAKAO MATSUBARA1,
  4. SHINICHI MIYAZAKI1,
  5. ATSUSHI OKAMURA1,
  6. MASASHI SETO1,
  7. AKIHIKO MATSUMINE1,
  8. HAJIME HOSOI3,
  9. TOURU SUGIMOTO3 and
  10. ATSUMASA UCHIDA1
  1. 1Department of Orthopaedic Surgery, Mie University Faculty of Medicine
  2. 2Department of Orthopedic Surgery, Kyoto Prefectural University of Medicine, Japan
  3. 3Department of Pediatrics, Kyoto Prefectural University of Medicine, Japan
  1. Correspondence to: Katsuyuki Kusuzaki, M.D., Department of Orthopaedic Surgery, Mie University Faculty of Medicine, Edobashi 2-174, Tsu city, Mie Prefecture 514-8507, Japan. Tel: +81 59 231 5022, Fax: +81 59 231 5211, e-mail: kusu{at}clini.medic.mie-u.ac.jp
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Clinical Trial of Photodynamic Therapy Using Acridine Orange with/without Low Dose Radiation as New Limb Salvage Modality in Musculoskeletal Sarcomas
KATSUYUKI KUSUZAKI, HIROAKI MURATA, TAKAO MATSUBARA, SHINICHI MIYAZAKI, ATSUSHI OKAMURA, MASASHI SETO, AKIHIKO MATSUMINE, HAJIME HOSOI, TOURU SUGIMOTO, ATSUMASA UCHIDA
Anticancer Research Mar 2005, 25 (2B) 1225-1235;
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section